Literature DB >> 24777856

DNGR-1 is dispensable for CD8+ T-cell priming during respiratory syncytial virus infection.

Lydia R Durant1, Catherine Pereira, Aime Boakye, Spyridon Makris, Fahima Kausar, Michelle Goritzka, Cecilia Johansson.   

Abstract

During respiratory syncytial virus (RSV) infection CD8(+) T cells both assist in viral clearance and contribute to immunopathology. CD8(+) T cells recognize viral peptides presented by dendritic cells (DCs), which can directly present viral antigens when infected or, alternatively, "cross-present" antigens after endocytosis of dead or dying infected cells. Mouse CD8α(+) and CD103(+) DCs excel at cross-presentation, in part because they express the receptor DNGR-1 that detects dead cells by binding to exposed F-actin and routes internalized cell debris into the cross-presentation pathway. As RSV causes death in infected epithelial cells, we tested whether cross-presentation via DNGR-1 is necessary for CD8(+) T-cell responses to the virus. DNGR-1-deficient or wild-type mice were intranasally inoculated with RSV and the magnitude of RSV-specific CD8(+) T-cell induction was measured. We found that during live RSV infection, cross-presentation via DNGR-1 did not have a major role in the generation of RSV-specific CD8(+) T-cell responses. However, after intranasal immunization with dead cells infected with RSV, a dependence on DNGR-1 for RSV-specific CD8(+) T-cell responses was observed, confirming the ascribed role of the receptor. Thus, direct presentation by DCs may be the major pathway initiating CD8(+) T-cell responses to RSV, while DNGR-1-dependent cross-presentation has no detectable role.
© 2014 The Authors. European Journal of Immunology published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  CD8+ T cell; Cross-presentation; DNGR-1; Lung infection; Virus

Mesh:

Substances:

Year:  2014        PMID: 24777856     DOI: 10.1002/eji.201444454

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

1.  Alveolar macrophage-derived type I interferons orchestrate innate immunity to RSV through recruitment of antiviral monocytes.

Authors:  Michelle Goritzka; Spyridon Makris; Fahima Kausar; Lydia R Durant; Catherine Pereira; Yutaro Kumagai; Fiona J Culley; Matthias Mack; Shizuo Akira; Cecilia Johansson
Journal:  J Exp Med       Date:  2015-04-20       Impact factor: 14.307

2.  T cell responses are elicited against Respiratory Syncytial Virus in the absence of signalling through TLRs, RLRs and IL-1R/IL-18R.

Authors:  Michelle Goritzka; Catherine Pereira; Spyridon Makris; Lydia R Durant; Cecilia Johansson
Journal:  Sci Rep       Date:  2015-12-21       Impact factor: 4.379

3.  Neutrophils do not impact viral load or the peak of disease severity during RSV infection.

Authors:  Freja Kirsebom; Christina Michalaki; Marina Agueda-Oyarzabal; Cecilia Johansson
Journal:  Sci Rep       Date:  2020-01-24       Impact factor: 4.379

Review 4.  Neutrophils in respiratory viral infections.

Authors:  Cecilia Johansson; Freja C M Kirsebom
Journal:  Mucosal Immunol       Date:  2021-03-23       Impact factor: 7.313

5.  Gelsolin Attenuates Neonatal Hyperoxia-Induced Inflammatory Responses to Rhinovirus Infection and Preserves Alveolarization.

Authors:  Tracy X Cui; Alexander E Brady; Ying-Jian Zhang; Christina T Fulton; Antonia P Popova
Journal:  Front Immunol       Date:  2022-01-31       Impact factor: 7.561

6.  A novel peptide targeting Clec9a on dendritic cell for cancer immunotherapy.

Authors:  Zhongyi Yan; Yahong Wu; Jiangfeng Du; Guodong Li; Shengdian Wang; Wenpeng Cao; Xiuman Zhou; Chunjing Wu; Dan Zhang; Xueli Jing; Yifan Li; Hongfei Wang; Yanfeng Gao; Yuanming Qi
Journal:  Oncotarget       Date:  2016-06-28

7.  Long-lived tissue resident HIV-1 specific memory CD8+ T cells are generated by skin immunization with live virus vectored microneedle arrays.

Authors:  Marija Zaric; Pablo Daniel Becker; Catherine Hervouet; Petya Kalcheva; Barbara Ibarzo Yus; Clement Cocita; Lauren Alexandra O'Neill; Sung-Yun Kwon; Linda Sylvia Klavinskis
Journal:  J Control Release       Date:  2017-10-19       Impact factor: 9.776

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.